NOS3 and coronary artery disorder: Several prospective studies have shown that PPARγ agonists stimulate the production of endothelial nitric oxide synthase (eNOS) in human umbilical vein endothelial cells (HUVEC) [5,6] and increase the number and function of endothelial progenitor cells in patients with coronary artery disease [7].